Research output per year
Research output per year
Fingerprint
Dive into the research topics where Lori A. Rink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS): Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
Movva, S., Matloob, S., Handorf, E. A., Choy, E., Merriam, P., Flieder, D. B., Cai, K. Q., Zhou, Y., Tetzlaff, E. D., Pagan, C., Barker, E., Veggeberg, R., Zumpano, D., Rink, L., von Mehren, M. & George, S., Jan 15 2024, In: Clinical Cancer Research. 30, 2, p. 315-322 8 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Combined inhibition of AKT and KIT restores expression of programmed cell death 4 (PDCD4) in gastrointestinal stromal tumor
Kozinova, M., Joshi, S., Ye, S., Belinsky, M. G., Sharipova, D., Farma, J. M., Reddy, S. S., Litwin, S., Devarajan, K., Campos, A. R., Yu, Y., Schwartz, B., von Mehren, M. & Rink, L., Jun 23 2021, In: Cancers. 13, 15, 3699.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment
Ye, S., Sharipova, D., Kozinova, M., Klug, L., D’Souza, J., Belinsky, M. G., Johnson, K. J., Einarson, M. B., Devarajan, K., Zhou, Y., Litwin, S., Heinrich, M. C., DeMatteo, R., von Mehren, M., Duncan, J. S. & Rink, L., Jan 25 2021, In: JCI insight. 6, 2, e143474.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Linsitinib (OSI-906) for the treatment of adult and pediatric wild-type gastrointestinal stromal tumors, a SARC phase II study
Von Mehren, M., George, S., Heinrich, M. C., Schuetze, S. M., Yap, J. T., Yu, J. Q., Abbott, A., Litwin, S., Crowley, J., Belinsky, M., Janeway, K. A., Hornick, J. L., Flieder, D. B., Chugh, R., Rink, L. & Van Den Abbeele, A. D., Apr 15 2020, In: Clinical Cancer Research. 26, 8, p. 1837-1845 9 p.Research output: Contribution to journal › Article › peer-review
Open Access41 Scopus citations -
Combination of imatinib mesylate and AKT inhibitor provides synergistic effects in preclinical study of gastrointestinal stromal tumor
Zook, P., Pathak, H. B., Belinsky, M. G., Gersz, L., Devarajan, K., Zhou, Y., Godwin, A. K., Von Mehren, M. & Rink, L., Jan 1 2017, In: Clinical Cancer Research. 23, 1, p. 171-180 10 p.Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations
Press/Media
-
Studies Conducted at Fox Chase Cancer Center on Leiomyosarcoma Recently Published [SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS)]
Rink, L. A., Flieder, D. B., Zhou, Y. & von Mehren, M.
12/4/23
1 item of Media coverage
Press/Media
-
Fox Chase Cancer Center: Dr. Stephanie Greco Inducted as Fellow Into the American College of Surgeons
Rink, L. A., Greco, S. H., von Mehren, M. & Farma, J. M.
12/16/21
1 item of Media coverage
Press/Media
-
Investigational Combination Offers ‘High Hopes’ in Treating GISTArticle
03/23/21
1 item of Media coverage
Press/Media
-
Fox Chase Researcher Identifies Potential New Treatment Target for GI Tumors
12/29/20
1 item of Media coverage
Press/Media
-
Fox Chase Researcher Identifies Potential New Treatment Target for GI Tumors
12/29/20
1 item of Media coverage
Press/Media